Abstract
Adults living with congenital heart disease (CHD) now outnumber children with the disease. Thanks to medical advances over the past 75 years, many of these fatal childhood heart problems have changed to chronic medical conditions. As the population of adults with CHD increases, they will require increasingly complex medical, surgical and catheter-based therapies. In addition, social burdens including education, employment and insurability, which increase the societal costs of adult CHD, are now being recognized for adults living with CHD. This review summarizes the available literature on the economics of adult CHD.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 85-96 |
| Number of pages | 12 |
| Journal | Expert Review of Pharmacoeconomics and Outcomes Research |
| Volume | 16 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2 2016 |
Keywords
- Adult congenital heart disease
- atrial septal defects
- chronic disease
- economics
- healthcare resource utilization
- Hypoplastic left heart syndrome
- tetralogy of Fallot
ASJC Scopus subject areas
- Pharmacology (medical)
- Health Policy
Fingerprint Dive into the research topics of 'A review of the economics of adult congenital heart disease'. Together they form a unique fingerprint.
Cite this
Seckeler, M. D., Thomas, I. D., Andrews, J., Joiner, K. A., & Klewer, S. E. (2016). A review of the economics of adult congenital heart disease. Expert Review of Pharmacoeconomics and Outcomes Research, 16(1), 85-96. https://doi.org/10.1586/14737167.2016.1140575